292 related articles for article (PubMed ID: 3648856)
1. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
[No Abstract] [Full Text] [Related]
2. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors].
Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M
Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522
[No Abstract] [Full Text] [Related]
3. Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy.
De Paoli P; Reitano M; Battistin S; Martelli P; Villalata D; Bergamo F; Tirelli U; Carbone A; Diodato S; Bosio R
Clin Exp Immunol; 1986 Jun; 64(3):451-6. PubMed ID: 3024880
[TBL] [Abstract][Full Text] [Related]
4. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
[No Abstract] [Full Text] [Related]
6. [Significance of neopterin, gamma interferon and other immunologic parameters determined in a population of drug addicts, positive or negative for anti-HTLV III antibodies].
Soffritti E; Dallara G; Bernardoni R; Ferrari R; Pelizzola D; Cicognani I; Gallerani M; Colamussi V; Cazzuffi S; Scaglianti G
G Clin Med; 1987 Feb; 68(2):87-95. PubMed ID: 3111926
[No Abstract] [Full Text] [Related]
7. A clinical-immunological evaluation of AIDS cases and related syndromes.
Gritti FM; Raise E; Gualandi G; Bonazzi L; Martuzzi M; Schiattone ML; Di Pede B; Gallo R; Rivano MT; Taruscio D
J Exp Pathol; 1987; 3(4):723-36. PubMed ID: 3483882
[TBL] [Abstract][Full Text] [Related]
8. Relationship between immunodeficiency conditions and AIDS-associated retrovirus (ARV) infection in homosexual men and i.v. drug abusers in the Campania Region.
Castello G; Melillo G; D'Alessio V; Leonardi E; Zarrilli D; Cataldo PT; Chirianni A; de Mercato R; Piazza M
Haematologica; 1986; 71(6):453-7. PubMed ID: 3104152
[No Abstract] [Full Text] [Related]
9. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
Pont J; Neuwald C; Kunz C; Werdenich W
Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
[TBL] [Abstract][Full Text] [Related]
10. [Immunological abnormalities in intravenous drug addicts in relation to contact with the HTLV III/LAV virus].
Besalduch Vidal J; Sanchís Cervera J; Miralles Bacete E; Vila Pastor B; Balaguer Muñoz H; Gil García S
Med Clin (Barc); 1987 May; 88(18):715-8. PubMed ID: 3497319
[No Abstract] [Full Text] [Related]
11. Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations.
Ferrante P; Nardi G; Zanchetta N; Salvioni PM; Pagano A
Boll Ist Sieroter Milan; 1986; 65(5):357-60. PubMed ID: 3030363
[TBL] [Abstract][Full Text] [Related]
12. [AIDS: an assessment of the potential occupational risk in the dental environment for HIV (human immunodeficiency virus) infection].
Avoni A; Borea G; Chiodo F; Costigliola P; Ricchi E
Minerva Stomatol; 1986 Oct; 35(10):941-6. PubMed ID: 3467166
[No Abstract] [Full Text] [Related]
13. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.
Robert-Guroff M; Oleske JM; Connor EM; Epstein LG; Minnefor AB; Gallo RC
Pediatr Res; 1987 Jun; 21(6):547-50. PubMed ID: 3474582
[TBL] [Abstract][Full Text] [Related]
14. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological survey of HIV infection in the Veneto region of Italy.
Chieco Bianchi L; Faulkner Valle G; De Rossi A; Dalla Gassa O
Biomed Pharmacother; 1987; 41(3):139-43. PubMed ID: 3038208
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiologic and clinical study of HIV infection in Cagliari].
Farci P; Lai ME; Orgiana G; Chessa L; Casula P; Arnone M; Bolasco P; Bolasco F; Altieri P; Balestrieri A
Recenti Prog Med; 1987 Dec; 78(12):539-42. PubMed ID: 3502504
[No Abstract] [Full Text] [Related]
17. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
Soranzo ML; Salassa B; Daziano E; Paggi GC
Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
[TBL] [Abstract][Full Text] [Related]
18. Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.
Aidoo M; Nishiwaki O; Akari H; Brandful JA; Ampofo W; Hayami M; Ayisi NK
West Afr J Med; 1994; 13(3):150-1. PubMed ID: 7841103
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of antibodies against HTLV-III in the at risk population in Madrid. Clinical study and incidence of virologic markers].
González Lahoz JM; Gutiérrez Angulo MT; Polo Rodríguez R; Subirats Núñez M; Moreno Celda V; Baquero Mochales M
Rev Clin Esp; 1987 May; 180(8):416-9. PubMed ID: 3649830
[No Abstract] [Full Text] [Related]
20. Epidemiological aspects of HTLV-III infection in Italy.
Rossi P; Carbonari M; Bonomo R; Galli M; Manconi PE; Scarpati B; Scano G; Gaetano C; Ensoli B; Aiuti F
Eur J Epidemiol; 1985 Dec; 1(4):288-93. PubMed ID: 3879841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
